查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1642423

止咳藥市場 - 全球產業分析、規模、佔有率、成長、趨勢及2032年預測

Cough Suppressant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 179 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

全球咳嗽藥市場規模上升，預計到2025年將激增至 287.5億美元，到2032年將進一步成長至 443.8億美元。這種擴張是由於呼吸系統疾病的增加、消費者意識的增強以及藥物解決方案的進步，年複合成長率為 6.4%。

止咳藥是指處方用來減輕咳嗽衝動的藥物。這些藥物透過影響大腦的咳嗽反射來發揮作用，有助於緩解呼吸道感染、過敏原和環境污染物引起的症狀。市場經歷一波創新浪潮，包括新的藥物組合和增強的給藥機制，目的是提高患者的便利性和治療效果。

隨著消費者健康意識的增強，非處方（OTC）止咳藥的需求也隨之增加。由於污染、季節性感染、過敏原等原因導致的呼吸系統疾病的流行推動市場擴張。消費者積極尋求治療持續咳嗽的有效方法，推動了止咳產品的銷售。公司優先開發能夠提高療效並減少副作用的配方。市場轉向整合多種活性成分的聯合療法，以提供全面的緩解。較方便的劑型，如液體膠囊、錠劑和噴霧劑，越來越受到消費者的歡迎。

本報告研究了全球咳嗽藥市場，並提供了市場概述以及有關市場類型、藥物類型、配方、通路、區域趨勢和參與市場的公司競爭動態的資訊。

目錄

第1章 執行摘要

第2章 市場概覽

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE 分析

第3章 定價分析，2019-2023年

第4章 2019年至2032年全球止咳藥市場展望

  • 2019年至2032年全球止咳藥市場展望，依類型、價值（十億美元）、數量（單位）
  • 2019年至2032年全球止咳藥市場展望，依藥物類型、價值（十億美元）、數量（單位）
  • 2019年至2032年全球咳嗽藥市場展望，依配方、價值（十億美元）和數量（單位）
  • 2019年至2032年全球咳嗽藥市場展望，依通路、價值（十億美元）和數量（單位）
  • 2019年至2032年全球咳藥市場展望，依地區、價值（十億美元）、數量（單位）

第5章 2019年至2032年北美止咳藥市場展望

第6章 2019年至2032年歐洲止咳藥市場展望

第7章 2019-2032年亞太地區止咳藥市場展望

第8章 2019-2032年拉丁美洲咳嗽藥市場展望

第9章 2019年至2032年中東、非洲止咳藥市場展望

第10章 競爭格局

  • 依類型和依藥物劃分的熱圖
  • 2024年公司市場佔有率分析
  • 競爭資訊中心
  • 公司簡介
    • Abbott Laboratories
    • Acella Pharmaceuticals, LLC
    • GlaxoSmithKline Plc
    • Johnson & Johnson services Inc.
    • Merck KGaA
    • Novartis International AG
    • Pfizer Inc.
    • Procter & Gamble

第11章 附錄

簡介目錄

The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.

Market Dynamics

Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.

Growth Drivers

Increasing Health Consciousness & Respiratory Conditions

  • A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
  • The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
  • Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.

Innovation & Expansion in Product Offerings

  • Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
  • The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
  • More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.

Business Opportunities

Development of Pediatric-Specific Products

  • Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
  • Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.

Demand for Natural & Herbal Cough Remedies

  • The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
  • Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.

Market Challenges

Regulatory Constraints

  • Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
  • Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.

Supply Chain Issues

  • Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
  • Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
  • Companies must adopt resilient supply chain strategies to maintain consistent distribution.

Regional Insights

Europe: Market Leader

  • The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
  • Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
  • A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.

South Asia & Pacific: Fastest-Growing Market

  • Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
  • Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
  • A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.

Leading Market Players

The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:

  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson Services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

Noteworthy Developments

New Product Introductions

  • 2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
  • Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.

Strategic Acquisitions

  • 2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
  • Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.

Market Segmentation

The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.

By Type:

  • Acute Cough
  • Chronic Cough

By Active Ingredients:

  • Dextromethorphan
  • Codeine
  • Butramirate
  • Benzonatate
  • Others

By Form:

  • Tablets/Capsules
  • Liquid Syrups
  • Sprays

By Sales Channels:

  • Hospitals
  • Retail Pharmacies
  • Drug Stores
  • E-commerce Platforms

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cough Suppressant Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

  • 3.1. Global Average Price Analysis by Type, 2019 - 2023
  • 3.2. Prominent Factor Affecting Cough Suppressant Prices
  • 3.3. Global Average Price Analysis by Region

4. Global Cough Suppressant Market Outlook, 2019 - 2032

  • 4.1. Global Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Acute Cough
      • 4.1.1.2. Chronic Cough
  • 4.2. Global Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dextromethorphan
      • 4.2.1.2. Codeine
      • 4.2.1.3. Butramirate
      • 4.2.1.4. Bennzonatate
      • 4.2.1.5. Others
  • 4.3. Global Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Solid
      • 4.3.1.2. Liquid
      • 4.3.1.3. Spray
  • 4.4. Global Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Hospitals
      • 4.4.1.2. Retail Pharmacies
      • 4.4.1.3. Drug Stores
      • 4.4.1.4. Online Pharmacies
  • 4.5. Global Cough Suppressant Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. North America
      • 4.5.1.2. Europe
      • 4.5.1.3. Asia Pacific
      • 4.5.1.4. Latin America
      • 4.5.1.5. Middle East & Africa

5. North America Cough Suppressant Market Outlook, 2019 - 2032

  • 5.1. North America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Acute Cough
      • 5.1.1.2. Chronic Cough
  • 5.2. North America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dextromethorphan
      • 5.2.1.2. Codeine
      • 5.2.1.3. Butramirate
      • 5.2.1.4. Bennzonatate
      • 5.2.1.5. Others
  • 5.3. North America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Solid
      • 5.3.1.2. Liquid
      • 5.3.1.3. Spray
  • 5.4. North America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Hospitals
      • 5.4.1.2. Retail Pharmacies
      • 5.4.1.3. Drug Stores
      • 5.4.1.4. Online Pharmacies
    • 5.4.2. Attractiveness Analysis
  • 5.5. North America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. U.S. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.2. U.S. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.3. U.S. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.4. U.S. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.5. Canada Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.6. Canada Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.7. Canada Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.5.1.8. Canada Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Cough Suppressant Market Outlook, 2019 - 2032

  • 6.1. Europe Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Acute Cough
      • 6.1.1.2. Chronic Cough
  • 6.2. Europe Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dextromethorphan
      • 6.2.1.2. Codeine
      • 6.2.1.3. Butramirate
      • 6.2.1.4. Bennzonatate
      • 6.2.1.5. Others
  • 6.3. Europe Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Solid
      • 6.3.1.2. Liquid
      • 6.3.1.3. Spray
  • 6.4. Europe Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Hospitals
      • 6.4.1.2. Retail Pharmacies
      • 6.4.1.3. Drug Stores
      • 6.4.1.4. Online Pharmacies
    • 6.4.2. Attractiveness Analysis
  • 6.5. Europe Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. Germany Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.2. Germany Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.3. Germany Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.4. Germany Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.5. U.K. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.6. U.K. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.7. U.K. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.8. U.K. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.9. France Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.10. France Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.11. France Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.12. France Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.13. Italy Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.14. Italy Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.15. Italy Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.16. Italy Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.17. Turkey Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.18. Turkey Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.19. Turkey Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.20. Turkey Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.21. Russia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.22. Russia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.23. Russia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.24. Russia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.25. Rest of Europe Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.26. Rest of Europe Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.27. Rest of Europe Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.5.1.28. Rest of Europe Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Cough Suppressant Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Acute Cough
      • 7.1.1.2. Chronic Cough
  • 7.2. Asia Pacific Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dextromethorphan
      • 7.2.1.2. Codeine
      • 7.2.1.3. Butramirate
      • 7.2.1.4. Bennzonatate
      • 7.2.1.5. Others
  • 7.3. Asia Pacific Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Solid
      • 7.3.1.2. Liquid
      • 7.3.1.3. Spray
  • 7.4. Asia Pacific Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Hospitals
      • 7.4.1.2. Retail Pharmacies
      • 7.4.1.3. Drug Stores
      • 7.4.1.4. Online Pharmacies
    • 7.4.2. Attractiveness Analysis
  • 7.5. Asia Pacific Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. China Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.2. China Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.3. China Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.4. China Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.5. Japan Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.6. Japan Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.7. Japan Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.8. Japan Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.9. South Korea Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.10. South Korea Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.11. South Korea Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.12. South Korea Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.13. India Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.14. India Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.15. India Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.16. India Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.17. Southeast Asia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.18. Southeast Asia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.19. Southeast Asia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.20. Southeast Asia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.21. Rest of Asia Pacific Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.22. Rest of Asia Pacific Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.23. Rest of Asia Pacific Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.5.1.24. Rest of Asia Pacific Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Cough Suppressant Market Outlook, 2019 - 2032

  • 8.1. Latin America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Acute Cough
      • 8.1.1.2. Chronic Cough
  • 8.2. Latin America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dextromethorphan
      • 8.2.1.2. Codeine
      • 8.2.1.3. Butramirate
      • 8.2.1.4. Bennzonatate
      • 8.2.1.5. Others
  • 8.3. Latin America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Solid
      • 8.3.1.2. Liquid
      • 8.3.1.3. Spray
  • 8.4. Latin America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Hospitals
      • 8.4.1.2. Retail Pharmacies
      • 8.4.1.3. Drug Stores
      • 8.4.1.4. Online Pharmacies
    • 8.4.2. Attractiveness Analysis
  • 8.5. Latin America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. Brazil Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.2. Brazil Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.3. Brazil Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.4. Brazil Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.5. Mexico Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.6. Mexico Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.7. Mexico Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.8. Mexico Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.9. Argentina Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.10. Argentina Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.11. Argentina Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.12. Argentina Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.13. Rest of Latin America Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.14. Rest of Latin America Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.15. Rest of Latin America Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.5.1.16. Rest of Latin America Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Cough Suppressant Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Acute Cough
      • 9.1.1.2. Chronic Cough
  • 9.2. Middle East & Africa Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Dextromethorphan
      • 9.2.1.2. Codeine
      • 9.2.1.3. Butramirate
      • 9.2.1.4. Bennzonatate
      • 9.2.1.5. Others
  • 9.3. Middle East & Africa Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Solid
      • 9.3.1.2. Liquid
      • 9.3.1.3. Spray
  • 9.4. Middle East & Africa Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. Hospitals
      • 9.4.1.2. Retail Pharmacies
      • 9.4.1.3. Drug Stores
      • 9.4.1.4. Online Pharmacies
    • 9.4.2. Attractiveness Analysis
  • 9.5. Middle East & Africa Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1. Key Highlights
      • 9.5.1.1. GCC Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.2. GCC Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.3. GCC Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.4. GCC Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.5. South Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.6. South Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.7. South Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.8. South Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.9. Egypt Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.10. Egypt Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.11. Egypt Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.12. Egypt Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.13. Nigeria Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.14. Nigeria Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.15. Nigeria Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.16. Nigeria Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.17. Rest of Middle East & Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.18. Rest of Middle East & Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.19. Rest of Middle East & Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.5.1.20. Rest of Middle East & Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

  • 10.1. By Type vs by Drugs Heatmap
  • 10.2. Company Market Share Analysis, 2024
  • 10.3. Competitive Dashboard
  • 10.4. Company Profiles
    • 10.4.1. Abbott Laboratories
      • 10.4.1.1. Company Overview
      • 10.4.1.2. Product Portfolio
      • 10.4.1.3. Financial Overview
      • 10.4.1.4. Business Strategies and Development
    • 10.4.2. Acella Pharmaceuticals, LLC
      • 10.4.2.1. Company Overview
      • 10.4.2.2. Product Portfolio
      • 10.4.2.3. Financial Overview
      • 10.4.2.4. Business Strategies and Development
    • 10.4.3. GlaxoSmithKline Plc
      • 10.4.3.1. Company Overview
      • 10.4.3.2. Product Portfolio
      • 10.4.3.3. Financial Overview
      • 10.4.3.4. Business Strategies and Development
    • 10.4.4. Johnson & Johnson services Inc.
      • 10.4.4.1. Company Overview
      • 10.4.4.2. Product Portfolio
      • 10.4.4.3. Financial Overview
      • 10.4.4.4. Business Strategies and Development
    • 10.4.5. Merck KGaA
      • 10.4.5.1. Company Overview
      • 10.4.5.2. Product Portfolio
      • 10.4.5.3. Financial Overview
      • 10.4.5.4. Business Strategies and Development
    • 10.4.6. Novartis International AG
      • 10.4.6.1. Company Overview
      • 10.4.6.2. Product Portfolio
      • 10.4.6.3. Financial Overview
      • 10.4.6.4. Business Strategies and Development
    • 10.4.7. Pfizer Inc.
      • 10.4.7.1. Company Overview
      • 10.4.7.2. Product Portfolio
      • 10.4.7.3. Financial Overview
      • 10.4.7.4. Business Strategies and Development
    • 10.4.8. Procter & Gamble
      • 10.4.8.1. Company Overview
      • 10.4.8.2. Product Portfolio
      • 10.4.8.3. Financial Overview
      • 10.4.8.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations